Immucell (ICCC) Operating Income (2016 - 2025)
Historic Operating Income for Immucell (ICCC) over the last 16 years, with Q3 2025 value amounting to $20075.0.
- Immucell's Operating Income rose 10349.19% to $20075.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year increase of 20296.71%. This contributed to the annual value of -$1.6 million for FY2024, which is 7146.6% up from last year.
- Per Immucell's latest filing, its Operating Income stood at $20075.0 for Q3 2025, which was up 10349.19% from $569562.0 recorded in Q2 2025.
- In the past 5 years, Immucell's Operating Income ranged from a high of $1.1 million in Q1 2025 and a low of -$2.3 million during Q1 2023
- Moreover, its 5-year median value for Operating Income was -$337338.5 (2021), whereas its average is -$373279.7.
- Its Operating Income has fluctuated over the past 5 years, first crashed by 122353.45% in 2022, then surged by 47247.68% in 2025.
- Immucell's Operating Income (Quarter) stood at $145412.0 in 2021, then plummeted by 1223.53% to -$1.6 million in 2022, then increased by 27.53% to -$1.2 million in 2023, then soared by 152.48% to $621395.0 in 2024, then crashed by 96.77% to $20075.0 in 2025.
- Its last three reported values are $20075.0 in Q3 2025, $569562.0 for Q2 2025, and $1.1 million during Q1 2025.